RE: NT to buy7 Feb 2025 09:50
We’re proud to announce our collaboration with Johnson & Johnson to pilot the Trellus Elevate® platform in the U.S., bringing holistic support to patients with moderately to severely active inflammatory bowel disease (IBD). Through this one-year partnership, eligible patients prescribed a Johnson & Johnson therapy will gain access to Trellus Elevate®, empowering them with the tools and confidence to navigate the emotional and physical challenges of their condition and take control of their health journey.
As Marla Dubinsky, CEO of Trellus Health, shares: "We have reached a therapeutic ceiling with many existing treatments for IBD, and it is only by addressing both the mind and body that we can break through that barrier."